Pablo Castro
← Back to Pontificia Universidad Católica de Chile
Pontificia Universidad Católica de Chile
Pablo Castro works in Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Acute Myocardial Infarction Research, Cardiac Fibrosis and Remodeling, Pulmonary Hypertension Research and Treatments. Recorded institutional associations include Pontificia Universidad Católica de Chile, Advanced Center for Chronic Diseases.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat
2006 · 273 citationsVCAM-1 as a predictor biomarker in cardiovascular disease
2021 · 224 citationsACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension
2015 · 157 citationsNanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches
2018 · 152 citationsThe Reality of Heart Failure in Latin America
2013 · 148 citationsLow-Grade Chronic Inflammation: a Shared Mechanism for Chronic Diseases
2024 · 139 citationsComparison of a Radiofrequency-Based Wireless Pressure Sensor to Swan-Ganz Catheter and Echocardiography for Ambulatory Assessment of Pulmonary Artery Pressure in Heart Failure
2007 · 125 citationsER-to-mitochondria miscommunication and metabolic diseases
2015 · 116 citationsNew Molecular Insights of Insulin in Diabetic Cardiomyopathy
2016 · 111 citationsInhibition of mitochondrial fission prevents hypoxia-induced metabolic shift and cellular proliferation of pulmonary arterial smooth muscle cells
2017 · 82 citationsPleiotropic Effects of Atorvastatin in Heart Failure: Role in Oxidative Stress, Inflammation, Endothelial Function, and Exercise Capacity
2008 · 71 citationsDinámica mitocondrial: un potencial nuevo blanco terapéutico para la insuficiencia cardiaca
2011 · 67 citationsMitochondrial Dynamics: a Potential New Therapeutic Target for Heart Failure
2011 · 66 citationsMitochondria, Myocardial Remodeling, and Cardiovascular Disease
2012 · 63 citationsDefective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy
2015 · 61 citationsTrimetazidine prevents palmitate-induced mitochondrial fission and dysfunction in cultured cardiomyocytes
2014 · 53 citationsStudy protocol for the Maule Cohort (MAUCO) of chronic diseases, Chile 2014–2024
2015 · 52 citationsGene Polymorphisms for Plasminogen Activator Inhibitor-1/Tissue Plasminogen Activator and Development of Allograft Coronary Artery Disease
1998 · 50 citationsAdministration of growth hormone to patients with advanced cardiac heart failure: effects upon left ventricular function, exercise capacity, and neurohormonal status
2003 · 50 citationsBasal autophagy protects cardiomyocytes from doxorubicin-induced toxicity
2016 · 48 citationsA Wireless Pressure Sensor for Monitoring Pulmonary Artery Pressure in Advanced Heart Failure: Initial Experience
2007 · 47 citationsEndoplasmic reticulum−mitochondria coupling increases during doxycycline-induced mitochondrial stress in HeLa cells
2021 · 43 citationsSerum Uric Acid Correlates with Extracellular Superoxide Dismutase Activity in Patients with Chronic Heart Failure
2008 · 42 citationsSocioeconomic Inequalities in Heart Failure
2015 · 41 citationsOxidative stress after reperfusion with primary coronary angioplasty: Lack of effect of glucose-insulin-potassium infusion
2002 · 41 citations
